住院患者血乳酸和血氨的检测流程优化及质量提升

doi:10.3969/j.issn.1673-8640.2021.04.004

摘要/Abstract

摘要：

目的探讨同济大学附属同济医院住院患者乳酸和血氨项目检测结果阳性率高的原因,并制定改进措施,提高乳酸和血氨检测的准确性。方法以乳酸>2.2 mmol/L或血氨>30 μmol/L为阳性,分别统计同济大学附属同济医院2019年1—6月门诊、急诊、住院和住院急诊患者样本乳酸及血氨项目的总检测数、检测结果阳性率以及检验流程各节点的耗时。随机收集40份临床样本,分别在样本采集后的15、30、45、60、90、120、180 min检测乳酸和血氨,以15 min检测结果为基准值,分别计算后续时间点检测结果与基准值之间的偏差。制定改进措施并实施后,分别统计乳酸和血氨项目检测结果的阳性率及检测流程各节点耗时的变化。结果 2019年1—6月,门诊、急诊、住院急诊和住院患者样本乳酸项目检测结果的阳性率分别为36.87%、50.73%、58.28%、84.44%,血氨项目的阳性率分别为14.68%、13.48%、34.04%、72.67%。门诊、急诊、住院和住院急诊样本从样本采集到上机检测的中位时间分别为35、32、130和83 min。40份临床样本乳酸和血氨项目各时间点检测结果与基准值之间的偏差随时间的延长逐渐增大。检验流程改进后,住院患者样本乳酸和血氨项目检测结果的阳性率分别下降至32.59%、22.65%,住院患者样本从样本采集到上机检测的耗时缩短至43 min。结论改进检验前流程有效缩短了住院患者样本从样本采集到上机检测的耗时,降低了乳酸和血氨项目检测结果的阳性率,提高了准确性。

关键词: 乳酸, 血氨, 检验质量, 流程优化

Abstract:

Objective To find out the reasons for high positive rate of blood lactic acid and ammonia determination results among the inpatients in Tongji Hospital affiliated to Tongji University,and to take measures to improve the accuracy of blood lactic acid and ammonia determination results. Methods With blood lactic acid >2.2 mmol/L and blood ammonia >30 μmol/L indicating positive results,the total number and positive rate of blood lactic acid and ammonia determinations and the time used for each link in the determination process in the outpatient,emergency,inpatient and inpatient emergency departments were calculated from January to June 2019. Totally,40 clinical samples were collected randomly,and blood lactic acid and ammonia were determined at 15,30,45,60,90,120 and 180 min after sample collection. With the results at 15 min as the baseline values,the deviation between the means of the results at the subsequent time points and the baseline values was calculated. After improvement measures were formulated and implemented,the positive rate of blood lactic acid and ammonia determination results was calculated,and the changes in the time used for each link in the determination process were compared. Results The positive rates of blood lactic acid determinations were 36.87%,50.73%,58.28% and 84.44%,and those of blood ammonia determinations were 14.68%,13.48%,34.04% and 72.67% in the outpatient,emergency,inpatient and inpatient emergency departments from January to June 2019,respectively. The median times from sample collection to determination on machines were 35,32,130 and 83 min in the outpatient,emergency,inpatient and inpatient emergency departments,respectively. The deviations between the results and the baseline values of blood lactic acid and ammonia determination increased gradually over time in the 40 clinical samples. After the improvement of determination process,the positive rates decreased to 32.59% and 22.65% for blood lactic acid and ammonia determination results,respectively. The time used from sample collection to determination on machines was shortened to 43 min. Conclusions Through the optimization of pre-determination process,the time used from sample collection to determination on machines can be reduced effectively,so that the positive rates of blood lactic acid and ammonia determination results are decreased with improved accuracy.

Key words: Blood lactic acid, Blood ammonia, Determination quality, Process optimization

中图分类号:

R446.1

寄晓义, 李冬, 戴燕. 住院患者血乳酸和血氨的检测流程优化及质量提升[J]. 检验医学, 2021, 36(4): 374-377.

JI Xiaoyi, LI Dong, DAI Yan. Process optimization for determining blood lactic acid and ammonia in inpatients and its quality improvement[J]. Laboratory Medicine, 2021, 36(4): 374-377.

图/表 1

参考文献 8

[1]	丛玉隆, 尹一兵, 陈瑜. 检验医学高级教程[M]. 2版. 北京: 人民军医出版社, 2010.
[2]	PLEBANI M. Errors in clinical laboratories or errors in laboratory medicine?[J]. Clin Chem Lab Med, 2006,44(6):750-759. DOI URL PMID
[3]	李亚菊, 张晨, 陈锟. 分析前因素对血乳酸检测结果的影响[J]. 检验医学与临床, 2017,14(Z2):48-51.
[4]	白巨明. 样本放置时间及温度对血氨检测结果的影响[J]. 检验医学与临床, 2015,12(19):2941-2942.
[5]	全国卫生专业技术资格考试专家委员会. 临床医学检验技术(师)[M]. 北京: 人民卫生出版社, 2010.
[6]	LIPPI G, BANFI G, CHURCH S, et al. Preanalytical quality improvement. In pursuit of harmony,on behalf of European Federation for Clinical Chemistry and Laboratory Medicine(EFLM) Working group for Preanalytical Phase(WG-PRE)[J]. Clin Chem Lab Med, 2015,53(3):357-370. DOI URL PMID
[7]	肖林林, 杜颖, 刘维薇, 等. 医学实验室认可进程中分析前过程的流程优化与监控[J]. 检验医学, 2018,33(4):343-347.
[8]	段敏, 赵海建, 王薇, 等. 临床检验前和检验后质量控制的“五个正确”[J]. 临床检验杂志, 2018,36(7):520-522.

时间点/min	乳酸		血氨
时间点/min	检测结果/（mmol/L）	偏差/%	检测结果/（μmol/L）	偏差/%
15	2.11±0.79		42.4±21.8
30	2.15±0.80	1.90	46.5±24.5	9.47
45	2.17±0.78	2.84	49.6±24.8	16.90
60	2.26±0.80	7.11	50.3±27.0	18.51
90	2.37±0.80	12.32	55.0±30.1	29.56
120	2.43±0.81	15.17	56.8±31.1	33.78
180	2.69±0.86	27.49	65.8±33.8	55.01

时间点/min	乳酸		血氨
时间点/min	检测结果/（mmol/L）	偏差/%	检测结果/（μmol/L）	偏差/%
15	2.11±0.79		42.4±21.8
30	2.15±0.80	1.90	46.5±24.5	9.47
45	2.17±0.78	2.84	49.6±24.8	16.90
60	2.26±0.80	7.11	50.3±27.0	18.51
90	2.37±0.80	12.32	55.0±30.1	29.56
120	2.43±0.81	15.17	56.8±31.1	33.78
180	2.69±0.86	27.49	65.8±33.8	55.01

[1]	赵艳宏, 傅琳, 刘彪, 肖美芳. 海南地区3~14岁人群乳酸脱氢酶参考区间分析[J]. 检验医学, 2023, 38(11): 1041-1043.
[2]	宋爽, 孙静芳, 徐娜, 郭毅. 高荧光细胞和血清乳酸脱氢酶/胸腔积液腺苷脱氨酶比值在鉴别胸腔积液性质中的应用价值[J]. 检验医学, 2022, 37(1): 101-102.
[3]	吴大勇, 王少军, 周家吾. 老年脓毒症休克患者血乳酸、红细胞分布宽度水平与临床预后的关系[J]. 检验医学, 2021, 36(9): 929-931.
[4]	虞啸炫, 欧元祝, 唐立萍, 刘文彬, 林斐然, 葛丹红, 龚敬凯, 朱宇清. 甜菜碱在提高血清乳酸脱氢酶活性稳定性中的作用[J]. 检验医学, 2021, 36(6): 623-626.
[5]	孔存权, 连利霞. 临床常用指标在辅助诊断COVID-19中的价值[J]. 检验医学, 2021, 36(2): 206-208.
[6]	欧元祝, 龚敬凯, 林斐然, 唐立萍, 朱宇清, 刘佳, 王华梁. 血红蛋白、胆红素、乳糜对干化学法和酶速率法检测血氨的干扰研究[J]. 检验医学, 2021, 36(11): 1146-1150.
[7]	金伟峰, 李萍, 陈姝子, 孙佳琪, 方伟, 李丹, 朱丽萍, 朱莉莉, 林萍. 精神分裂症患者血清D-乳酸、二胺氧化酶、内毒素的变化[J]. 检验医学, 2021, 36(10): 1039-1041.
[8]	刘然, 李峰, 李玉梅, 刘佃香. 端粒酶、M2型丙酮酸激酶、乳酸联合检测鉴别诊断结核性及恶性胸腔积液的价值[J]. 检验医学, 2018, 33(4): 324-325.
[9]	肖林林, 杜颖, 刘维薇, 魏取好, 冯景. 医学实验室认可进程中分析前过程的流程优化与监控[J]. 检验医学, 2018, 33(4): 343-347.
[10]	董奕裕, 吴奕征, 沈丽丽, 陈群. 纳米颗粒增强透射免疫比浊法检测乳酸脱氢酶同工酶3方法的建立及性能评价[J]. 检验医学, 2017, 32(2): 138-142.
[11]	何亚利, 梁顺容, 范佳鑫. 多发性骨髓瘤患者和厚朴酚联合三氧化二砷治疗前后血清β₂-MG及LDH的变化[J]. 检验医学, 2016, 31(6): 449-452.
[12]	旦正尖措, 马越云, 周磊, 付晓蕊, 苏明权, 郝晓柯. devR基因调控的结核分枝杆菌细胞毒性的研究[J]. 检验医学, 2015, 30(6): 607-612.
[13]	李多孚, 陈郁琳, 夏雨. 胸水ADA、LDH诊断结核性胸膜炎的临床效能评价[J]. 检验医学, 2015, 30(10): 987-990.
[14]	邓拥军, 石英, 周俊, 吴立山, 沈敏. 基于IFCC参考测量程序实现常规检测系统量值溯源的可行性探索[J]. 检验医学, 2015, 30(10): 1039-1043.
[15]	朱征, 杨敏, 潘虹, 吴启晓, 陆芸芸. CIK细胞免疫治疗对肿瘤患者血清LDH、ADA水平的影响[J]. 检验医学, 2014, 29(8): 860-862.